Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

April 15, 2009 (Vol. 29, No. 8)

Focused Assays Lead to More Potent Drugs

Label-Free Remains No.1 Cell-Based Trend, but Electrophysiology Is Not Far Behind

  • The demand for new drugs is pushing companies to develop cell-based assays that focus on a specific cellular event, potentially leading to tailored and more potent therapies. These assays also hold promise to predict toxicity, improve extrapolation to humans, and identify optimal leads earlier in the drug-discovery process. The ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.